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types has not been analyzed for protective epitopes of peptides
4, 5, and 6. Therefore, it is of interest to compare the immunogenicities of peptides 4, 5, and 6 of the two TCP biotypes.
The effects of the immune response (Ir) gene were first
described in 1965 by McDeveitt and Sella (12). They showed
that a branched polymer composed of a backbone of L-lysine
with side chains of DL-alanine conjugated randomly with tyrosine-glutamate when emulsified in Freund’s complete adjuvant (FCA) was able to induce a robust Ab response in
C57BL/6 mice (H-2b) and only a low Ab response in CBA mice
(H-2k). This and similar phenomena were described as effects
of the Ir gene. Interestingly, the (C57BL/6 ⫻ CBA)F1 mice
made intermediate responses. These results, along with results
from an F1 ⫻ C57BL/6 cross that showed a predominantly high
response, suggested that a single gene was controlling the serologic response. Long-term studies using congenic mice
clearly implicated the H-2 locus between K and Ss as containing the genes that controlled this phenomenon. Subsequent
studies have shown that the major histocompatibility complex
class II (MHC-II) molecules are critical for induction of Ab
responses and that it is the associated genes in the H-2 locus
that mediate the effects of the Ir gene. In the past 35 years,
scientists have defined the role of class II in the induction of
CD4⫹ T-cell help for Ab formation. We know that binding
peptide antigens (a fragment of the B-cell-internalized antigen) in the class II binding cleft is critical for B-cell presentation of the complex to CD4⫹ T helper cells. The allelic variations in class II molecules among the H-2 types dictate the
ability to bind peptides and thus the capacity to activate antigen-specific CD4⫹ T cells (2, 5, 14, 23). There is a compelling
data set that indicates that the peptide and H-2 sequences must
be optimized for effective presentation to induce T-cell help.
If subunit vaccines based on protein sequences are to be
useful, they must be able to induce responses in a large per-

Cholera is an acute diarrheal disease caused by the gramnegative bacterium Vibrio cholerae. The major secreted or surface-expressed virulence factors of V. cholerae are cholera
toxin and toxin-coregulated pilus (TCP) (7; reviewed in reference 9). TCP is a type 4 pilus composed of a homopolymer of
20.5-kDa TcpA pilin subunits that mediate V. cholerae colonization (8, 11, 20, 22). The TCP is allelic, i.e., there are two
predominant biotype-specific derivatives of TcpA (classical
and El Tor), which differ by 18.1% at the protein level in the
region defined by amino acids 145 to 199 (15). TcpA and
peptides derived from it are immunogenic and induce protective antibodies (Abs) when not delivered in the context of a
natural infection or vaccination with intact bacteria (7, 16–19).
Anti-TCP Abs when mixed with virulent V. cholerae (500 times
the 50% lethal dose [LD50]) and fed to infant mice provide
almost complete immunity to cholera (16, 17). The regions of
classical TcpA that neutralizing Abs are directed against have
been partially defined. Results of several experimental approaches have indicated that domains within the C-terminal
region of TcpA (amino acids 145 to 199) delineated by a single
disulfide bond can induce the protective Ab response seen in
animals (16, 17). Peptides Cl-4, Cl-5, and Cl-6 induce immune
responses in mice that can protect 50 to 89% of infant mice
against a 100LD50 challenge in the infant mouse cholera model
(17). Recent results (24) have further demonstrated that
TcpA-derived peptides and new experimental polymer adjuvants induce Ab responses in female mice that protect their
pups from V. cholerae infection. The previous studies were
focused on the classical biotype of TCP. TCP of El Tor bio* Corresponding author. Mailing address: Dartmouth Medical
School, Department of Microbiology and Immunology, 630W Borwell
Bldg., Lebanon, NH 03756. Phone: (603) 650-6896. Fax: (603) 6506223. E-mail: william.wade@dartmouth.edu.
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Cholera is an enteric disease caused by Vibrio cholerae. Toxin-coregulated pilus (TCP), a type 4 pilus
expressed by V. cholerae, is a cholera virulence factor that is required for host colonization. The TCP polymer
is composed of subunits of TcpA pilin. Antibodies directed against TcpA are protective in animal models of
cholera. While natural or recombinant forms of TcpA are difficult to purify to homogeneity, it is anticipated
that synthesized TcpA peptides might serve as immunogens in a subunit vaccine. We wanted to assess the
potential for effects of the immune response (Ir) gene that could complicate a peptide-based vaccine. Using a
panel of mice congenic at the H-2 locus we tested the immunogenicity of TcpA peptide sequences (peptides 4
to 6) found in the carboxyl termini of both the classical (Cl) and El Tor (ET) biotypes of TCP. Cl peptides have
been shown to be immunogenic in CD-1 mice. Our data clearly establish that there are effects of the Ir gene
associated with both biotypes of TcpA. These effects are dynamic and dependent on the biotype of TcpA and
the haplotypes of the host. In addition to the effects of the classic class II Ir gene, class I (D, L) or nonclassical
class I (Qa-2) may also affect immune responses to TcpA peptides. To overcome the effects of the class II Ir
gene, multiple TcpA peptides similar to peptides 4, 5, and 6 could be used in a subunit vaccine formulation.
Identification of the most protective B-cell epitopes of TcpA within a particular peptide and conjugation to a
universal carrier may be the most effective method to eliminate the effects of the class II and class I Ir genes.
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MATERIALS AND METHODS
Animals. Three- to 5-week-old female congenic mice were purchased from
Jackson Laboratory (Bar Harbor, Maine). At 8 weeks, 4 to 6 mice per haplotype
group were immunized as described below. The congenic mouse strains used
were as follows: H-2k, B10.A-H2a H2-T18a/SgSnJ; H-2b, C.B10-H2b/LilMcdJ;
H-2d, B10.D2-H2d H2-T18c Hc 1/nSnJ, and H-2k, B10.BR-H2k H2-T18a/SgSnJ.
All mice were housed under standard conditions in the Animal Resources Center
located at the Dartmouth-Hitchcock Medical Center (Lebanon, N.H.) and maintained on a basic diet of Harlan (Madison, Wis.) Teklad sterilizable rodent feed.
Materials and reagents. FCA and Freund’s incomplete adjuvant (FIA) were
purchased from Sigma-Aldrich (St. Louis, Mo.). Phosphate-buffered saline
(PBS), blocking buffer (1⫻ PBS, 1% bovine serum albumin, 0.05% Tween 20),
wash buffer (1⫻ PBS, 0.05% Tween 20), binding buffer (0.1 M Na2HPO4, pH
9.0), and stop solution (0.18 M H2SO4) were all prepared in-house using chemicals purchased from Fisher Scientific (Pittsburgh, Pa.) and Sigma. Methoxyflurane (Metofane) was manufactured by Schering-Plough Animal Health Corp.
(Union, N.J.). Heparinized microhematocrit capillary tubes were purchased from
Fisher Scientific. Seal-Rite 1.5-ml Natural microcentrifuge tubes and 0.5-ml
self-standing microcentrifuge tubes with O-ring caps were purchased from USA
Scientific, Inc. Perfektum 5-ml glass needle-lock tip syringes and Popper 20gauge microemulsifying needles were purchased from Fisher Scientific. 3,3⬘,5,5⬘Tetramethylbenzidine (TMB) peroxidase substrate was purchased from Kirkegaard & Perry Laboratories (Gaithersburg, Md.). All horseradish peroxidaseconjugated secondary Abs were purchased from Southern Biotechnology Associates (Birmingham, Ala.). One-milliliter Luer-Lok latex-free syringes and 22gauge PrecisionGlide needles used to deliver the immunogens were
manufactured by Becton Dickinson and Co. and were purchased from the local
stockroom. Falcon PRO-BIND 96-well U-bottom assay plates used to dilute
antisera for enzyme-linked immunosorbent assay (ELISA) were purchased from
Fisher Scientific.
Peptides. TcpA fragment peptides 4, 5, and 6, derived from sequences of either
classical or El Tor biotypes of V. cholerae, were commercially prepared by
Macromolecular Resources (Colorado State University, Fort Collins, Colo.).
The peptides used in single letter amino acid code are as follows: ET-4, ADLG
DFETSVADAATGAGVIKSIA; ET-5, AATGAGVIKSIAPGSANLNLTNITH;
ET-6, LNLTNITHVEKLCTGTAPFTVAFGNS; Cl-4, ADLGDFENSAAAAET
GVGVIKSIA; Cl-5, AETGVGVIKSIAPASKNLDLTNITH; Cl-6, LDLTNIT
HVEKLCKGTAPFGVAFGNS. The relative positions of these peptides are
shown in Fig. 1. The lyophilized peptides were resuspended in 5.0% dimethyl
sulfoxide–water–0.25⫻ PBS to a final concentration of 0.5 mg/ml and stored at
⫺80°C in 1.0-ml aliquots until used.
Immunization and serum collection. Peptide antigen emulsions were prepared
by diluting peptides in 1⫻ PBS and then mixing with adjuvant in a 1:1 ratio. Mice
were administered peptides (25 g/mouse) via intraperitoneal injection (200
l/mouse) with FCA for the primary inoculation (day 0) and with FIA for the
secondary and tertiary inoculations (days 14 and 28). Preimmune sera were
collected 1 to 2 weeks before the primary immunization. The primary-response
sera were collected at day ⫹14, and the secondary- and tertiary-response sera
were collected at days ⫹28 and ⫹42, respectively.
Blood collection was conducted under light methoxyflurane anesthesia via the
orbital venous sinus and plexus or via the tail vein when necessary. The blood was
incubated for 30 min at 37°C immediately following collection and then kept at
4°C overnight. Samples were centrifuged at 4°C for 10 min at 10,000 ⫻ g, and 20to 25-l aliquots of sera were stored at ⫺20°C until used.

FIG. 1. Sequences and location of the synthetic peptides within the
context of amino acids 145 to 199 of classical and El Tor TcpA.
Peptides 4, 5, and 6 were synthesized based on the predicted amino
acid sequences from cloned classical and El Tor tcpA genes. Dashes,
amino acid sequences that are shared. Peptide lengths are as follows:
24-mer for Cl-4 and ET-4, 25-mer for Cl-5 and ET-5, and 26-mer for
Cl-6 and ET-6. Underlined sequences are shared between peptides 4
and 5, and 5 and 6 for the same biotype.

Serology. Costar 96-well, high-binding, flat-bottom microtiter plates (Corning
Incorporated Life Sciences, Acton, Mass.) were coated with 0.5 g of peptides in
100 l of 0.1 M Na2HPO4, pH 9.0, overnight at 4°C. Plates were washed four
times using a Molecular Devices (Sunnyvale, Calif.) Skan Washer 400 microplate
washer with 250 l of 1⫻ PBS–0.05% Tween 20. Nonspecific binding was
blocked using 200 l of 1⫻ PBS–0.05% Tween 20–1% bovine serum albumin for
1 h at room temperature. Plates were washed four more times, and 50 l of
serially twofold-diluted antiserum was added to each well and incubated at room
temperature for 2 h and then overnight at 4°C. The initial dilutions were 1:500
for preimmune and primary sera, 1:1,000 for secondary sera, and 1:2,000 for
tertiary sera, except for Cl-5 tertiary sera, for which a dilution of 1:2,500 was used
for the analysis. Plates were washed six times, and 50 l of horseradish peroxidase-labeled goat anti-mouse IgG1 (␥1 chain-specific) or IgG2a (␥2a chainspecific) detector antibodies (diluted 1:4,000) was added to each well and incubated at room temperature for 2 h protected from light. Plates were washed eight
times and were then developed with 100 l of 3,3⬘,5,5⬘-tetramethylbenzidine
peroxidase substrate for 15 to 30 min at room temperature. The reaction was
stopped with an equal volume of 0.18 M H2SO4. Optical densities were read
using a Dynex Technologies MRX microplate reader (Thermo Labsystems, Helsinki, Finland) using Dynex Revelation, version 3.04, software at 450 nm with 630
nm as the reference wavelength.
Data analysis and statistics. All calculations and statistical analyses were
performed with Microsoft Excel, version 9.0, and GraphPad Prism, version 3.0.
The end point titer was defined as the reciprocal of the dilution for the last
positive well for each sample after subtracting the background. Background
values were defined as twice the mean optical density for all blank wells on a
single microtiter plate. Wells containing the lowest dilution for prebleed samples
were chosen to be blank background wells. One blank well was selected for each
mouse on an individual plate.
Immune responses to the peptides by each haplotype were scored using the
following criteria. A ⫹ was awarded for each set of sera (primary, secondary, or
tertiary) if all the mice responded to the immunization. If only two sets of sera
responded e.g., secondary and tertiary, the group was scored ⫹⫹. If all the mice
associated with all three serum sets responded, the score was ⫹⫹⫹. A further
refinement in the scoring was based on the totality of the response. Responses by
more than one mouse, but not the entire group, for a particular sera set were
scored ⫹/⫺. If no mice or only one mouse in the group responded, the group was
scored ⫺. If more than one mouse, but not all the mice, showed a positive
response in the primary and secondary sera, yet the tertiary sera were all positive,
the group was scored ⫹/⫺/⫹/⫺/⫹. To generate the number for the comparison
of the immune index, groups were assigned scores based on the response pattern:
⫹, 5 points; ⫹/⫺, 2.5 points; ⫺, 0 points. The values for the responses of the mice
with various haplotypes to classical and El Tor TcpA peptides 4, 5, or 6 were
tabulated (see Table 2). In addition, the immunogenicities of the peptides across
the haplotypes were determined and related to IgG subclass responses.

RESULTS
We selected four congenic strains of mice that represent the
three most studied class II H-2 regions: H-2b, H-2k, and H-2d
(Fig. 2). B10.A, B10.D2, and B10.BR mice express both class II
isotypes, I-A and I-E, while C.B.10 mice express I-A only. We
anticipated that immunization with TcpA peptide 4, 5, or 6
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centage of the target population. Classical peptides 4, 5, and 6
are 24 to 26 amino acids in length. Thus, they are long enough
to contain both B-cell epitopes (binds surface immunoglobulin
to select a B cell) and T-cell epitopes (presented by class II to
provide T-cell help). This has been demonstrated for peptides
4 and 6 in CD-1 mice, which are outbred mice of the H-2q
haplotypes (24). The issue at hand is to determine if the serologic and protective responses to peptides 4, 5, and 6 are
indicative of universal T-cell epitopes for class II molecules or
whether the effects of the Ir gene will be evident from limited
amino acid sequences. In addition, the allelic differences between Cl and El Tor TCP biotypes could complicate a simple
assignment of reactivity based on H-2 type.
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would be immunogenic in mice of some of the haplotypes as
the peptides have previously been shown to provide for both Band T-cell activation in CD-1 mice (H-2q).
Cl-4 and ET-4. Following one intraperitoneal immunization
of peptides in FCA and two with peptides in FIA, sera representing primary, secondary, and tertiary responses were collected and analyzed by ELISA to determine the anti-Cl-4 and
anti-ET-4 titers (Fig. 3A [IgG1] and B [IgG2a]). The homologous systems were evaluated, e.g., the ET-4 peptide reacted
with ET-4-specific sera. H-2a, H-2d, and H-2k mice immunized
with Cl-4 responded well, making IgG1-specific Abs throughout the time course of immunization (Fig. 3A). H-2b mice were
nonresponders to Cl-4, but certain mice in the group responded significantly in individual bleeds to ET-4. The IgG1
responses of H-2d mice to ET-4 were modest, a finding which
differed from that reported for H-2d mice immunized with
Cl-4.
The IgG2a responses to Cl-4 for H-2a, H-2d, and H-2k mice
were also positive but of significantly less magnitude than the
IgG1 responses (Fig. 3B). The IgG2a responses to ET-4 of
H-2a and H-2k mice were comparable to the IgG1 response to
ET-4. H-2b mice did not respond to ET-4 with as much IgG2a
as IgG1. The IgG2a responses of H-2d mice to ET-4 were
variable and low.
If ET-4 or Cl-4 peptides were used as the immunogen, clear
effects of the Ir gene were evident in H-2b and H-2d mice. H-2b
mice responded to ET-4 but not Cl-4; H-2d mice responded
poorly to ET-4, as evidenced by the minimal production of
IgG1 Abs, but responded well to Cl-4. Both H-2k and H-2a
mice responded to Cl-4. Unexpectedly, H-2a mice responded
to ET-4 but H-2k mice did not. This is surprising since both
strains of mice express I-Ak/I-Ek. These mice, however, differ
in the MHC-I locus. H-2a mice express Ld and Dd, whereas
H-2k mice express Lk and Dk (Fig. 2). The H-2a mouse response to ET-4 for IgG2a was very robust compared to the
anti-IgG2a response to Cl-4. The rank orders of response of
the various haplotypes of mice to Cl-4 and ET-4 were as follows: Cl-4 (IgG1), H-2a ⫽ H-2k ⬎ H-2d (H-2b, 0); ET-4 (IgG1),

FIG. 3. Comparison of ELISA titers of classical and El Tor antipeptide 4 IgG1 (A) or IgG2a (B). End point titers are shown as the
reciprocal of the dilution for the last positive well for each serum
analyzed. Cl-4 or ET-4 was bound to the plates in 0.1 M Na2HPO4, pH
9.0, at a concentration of 5 g/ml. Preimmune and primary sera were
diluted to 1:500, secondary sera were diluted to 1:1,000, and tertiary
sera were diluted to 1:2,000. Dotted lines, baseline serum dilution.
Symbols above the lines are considered positive. Means are indicated
by solid lines.

H-2a ⫽ H-2b ⫽ H-2d (H-2k, 0); Cl-4 (IgG2), H-2a ⫽ H-2d ⫽
H-2k (H-2b, 0); ET-4 (IgG2), H-2a ⬎ H-2b ⫽ H-2d (H-2k, 0).
Cl-5 and ET-5. H-2a, H-2d, and H-2k mice responded with
robust IgG1 titers to Cl-5 (Fig. 4A). H-2b mice were again
nonresponders to Cl-5. The IgG2a responses to Cl-5 of all the
mice were low or absent (Fig. 4B). There was variability in
H-2d and H-2k mice in the secondary and tertiary responses
(IgG2a) to Cl-5, with not all of them responding. This was
clearly different from the IgG1 responses of mice in these two
haplotypes in which the overwhelming majority of the mice
responded earlier and with higher titers of anti-Cl-5 IgG1.
Clearly, for all mice that responded to immunization with Cl-5,
the IgG1 response was induced earlier and to a higher degree
than that for IgG2a.
As with immunization of mice with ET-4, immunization with
ET-5 revealed effects of the Ir gene. Specifically, H-2b mice did
not respond to Cl-5 (Fig. 4A and B). H-2d mice generated
marginal responses, thus marking H-2d mice as low responders
to ET-5. Similarly, H-2k mice generated low titers in response
to ET-5. It should be noted that the H-2a response to Cl-5 was
absent in the IgG2a analysis compared to an early consistently
high-titer IgG1 response (Fig. 4B). Interestingly, the H-2a and
H-2k mice that share class II molecules manifest the same
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FIG. 2. Congenic mouse genotypes in the H-2 locus. H-2 congenic
mice were purchased from Jackson Laboratory, and the genotypes are
presented as described in the supplier material. The number of backcrosses (BC) for each strain is shown, as is the percent identity of the
genome based on the number of backcrosses. B10.A mice are H-2a;
C.B.10 mice are H-2b; B.10.D2 mice are H-2d; B.10Br mice are H-2k.
Differences between H-2a and H-2k mice are in italics.
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FIG. 4. Comparison of ELISA titers of classical and El Tor antipeptide 5 IgG1 (A) or IgG2a (B). End point titers are shown as the
reciprocal of the dilution for the last positive well for each serum
analyzed. Cl-5 or ET-5 was bound to the plates in 0.1 M Na2HPO4, pH
9.0, at a concentration of 5 g/ml. Preimmune and primary sera were
diluted to 1:500, secondary sera were diluted to 1:1,000, and tertiary
sera were diluted to 1:2,000, except for classical sera, which were
diluted 1:2,500. Dotted lines, baseline serum dilution. Symbols above
the lines are considered positive. Means are indicated by solid lines.

qualitative response to Cl-5 or ET-5, which is in contrast to the
differential ET-4 responses made by mice of these two haplotypes. The rank orders of response of the various haplotypes of
mice to Cl-5 and ET-5 are as follows: Cl-5 (IgG1), H-2a ⬎ H-2d
⬎ H-2k (H-2b, 0); ET-5 (IgG1), H-2b ⬎ H-2a ⬎ H-2k (H-2d, 0);
Cl-5 (IgG2), H-2d ⫽ H-2k (H-2a and H-2b, 0); ET-5 (IgG2),
H-2a ⫽ H-2b (H-2d and H-2k, 0).
Cl-6 and ET-6. H-2a, H-2d, and H-2k mice responded to Cl-6
with IgG1-specific Abs throughout the immunization time
course, even though there was only one H-2d mouse that had a
positive response in the primary sera. As before, the H-2b
haplotype mice did not respond to the classical peptide, yet
they did respond to the ET-6 peptide. H-2b, H-2d, and H-2k
mice made IgG1 in response to ET-6, although the response of
H-2k mice was not as high as those of H-2d and H-2b mice. H-2a
haplotype mice were nonresponders to ET-6 but responded to
Cl-6. This is in contrast to H-2a mice responding to ET-4 and
ET-5. Immunization with either Cl-6 or ET-6 revealed a difference in the abilities of I-Ak/I-Ek mice to respond to a given
peptide. H-2a mice did not respond to ET-6 while H-2k mice
did. This was based on differences that map to the class I
region of H-2.

FIG. 5. Comparison of ELISA titers of classical and El Tor antipeptide 6 IgG1 (A) or IgG2a (B). End point titers are shown as the
reciprocal of the dilution for the last positive well for each serum
analyzed. Cl-6 or ET-6 were bound to the plates in 0.1 M Na2HPO4,
pH 9.0, at a concentration of 5 g/ml. Preimmune and primary sera
were diluted to 1:500, secondary sera were diluted to 1:1,000, and
tertiary sera were diluted to 1:2,000. Dotted lines, baseline serum
dilution. Symbols above the lines are considered positive.
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The response to IgG2a of the various congenic mice to Cl-6
was similar to the IgG1 response (Fig. 5B). The IgG2a responses to ET-6 by H-2b, H-2k, and H-2d mice were not as high
as the IgG1 responses. As with the IgG1 response, there was
no IgG2a response to ET-6 by H-2a mice. The IgG2a responses
to Cl-6 were generally as high as the IgG1 responses and thus
different from the IgG2a responses of mice to Cl-4 and Cl-5,
which were always lower than the IgG1 responses. The rank
order of responses of the various haplotypes of mice to Cl-6
and ET-6 are as follows: Cl-6 (IgG1), H-2a ⬎ H-2k ⬎ H-2d
(H-2b, 0); ET-6 (IgG1), H-2d ⬎ H-2k ⬎ H-2b (H-2a, 0); Cl-6
(IgG2), H-2d ⫽ H-2k ⬎ H-2a (H-2b, 0); ET-6 (IgG2), H-2k ⫽
H-2d ⬎ H-2b (H-2a, 0).
Cross-reactive B-cell epitopes in nonresponder peptide-haplotype combinations. The lack of a serologic response to a
TcpA peptide by a particular haplotype of mouse could be
related to a lack of B- or T-cell epitopes or both. The positive
serologic results for a given biotype peptide among one or
more of the haplotypes of mice indicate that there are B- and
T-cell epitopes present in Cl-4, -5, and -6 and in ET-4, -5, and
-6. If the Ig locus on which the expressed B-cell antigen receptor (binds B-cell epitope) repertoire is based is invariant, then
the abilities to bind B-cell epitopes on TcpA peptides should

VOL. 69, 2001
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TABLE 1. Cross-reactivity of B-cell epitopes between classical
and El Tor peptides 4, 5 and 6a
Peptide and
haplotype

Cl-4, H-2a
ET-4, H-2

a

ET-4, H-2b

Cl-4, H-2k
ET-5, H-2a
Cl-5, H-2a
ET-5, H-2b
Cl-5, H-2d
Cl-5, H-2k
Cl-6, H-2a
ET-6, H-2b
d

ET-6, H-2

Cl-6, H-2d
k

Cl-6, H-2

Titer for:
Cl peptide

ET peptide

401
402
1
3
24
22
406
408
417
419

1.56 ⫻ 106
3.13 ⫻ 105
7.81 ⫻ 106
1.56 ⫻ 106
6.25 ⫻ 104
6.25 ⫻ 104
1.56 ⫻ 106
7.81 ⫻ 106
1.25 ⫻ 104
3.13 ⫻ 105

3.13 ⫻ 105
3.13 ⫻ 105
7.81 ⫻ 106
7.81 ⫻ 106
6.25 ⫻ 104
6.25 ⫻ 104
1.25 ⫻ 104
3.13 ⫻ 105
1.25 ⫻ 104
1.25 ⫻ 104

6
7
421
422
31
32
426
427
436
437

0
0
1.56 ⫻ 106
7.81 ⫻ 106
0
0
1.56 ⫻ 106
3.13 ⫻ 105
7.81 ⫻ 106
3.13 ⫻ 105

6.25 ⫻ 104
1.25 ⫻ 104
0
0
1.25 ⫻ 104
1.25 ⫻ 104
3.13 ⫻ 105
1.25 ⫻ 104
0
0

441
442
28
30
44
50
452
473
460
472

7.81 ⫻ 106
1.56 ⫻ 106
1.25 ⫻ 104
7.81 ⫻ 106
2.50 ⫻ 103
2.50 ⫻ 103
3.13 ⫻ 105
6.25 ⫻ 104
3.13 ⫻ 105
7.81 ⫻ 106

1.25 ⫻ 104
1.25 ⫻ 104
6.25 ⫻ 104
1.56 ⫻ 106
3.13 ⫻ 105
1.56 ⫻ 106
0
0
0
6.25 ⫻ 104

ET/Cl

0.2
1

0.008
0.04
1
0.04

0
0
0.2
0.04
0
0
0.002
0.008

0
0
0
0.008

Cl/ET

1
0.2
1
1

0
0
0
0

0.2
5.0
0.008
0.002

a
Tertiary sera for two individual mice for selected biotype-specific antiserum
peptides were analyzed for reactivity by ELISA. Not all the sera for all the
combinations presented in Fig. 2 to 4 were analyzed in this table. End-point titers
were calculated for each serum and ratios of titers were calculated for classical
antisera against classical peptide or El Tor peptide (Cl/ET) or for El Tor antisera
against El Tor peptide or classical peptide (ET/Cl). Ratios of cross-reactivity
were calculated by dividing the heterologous titer by the homologous titer.
Ratios of 1 to 0.04 were considered indicative of highly cross-reactive sera. Ratios
that produced a quotient of 0 were considered descriptive of non-cross-reactive
sera. Ratios of ⬎0.04 to 0.002 were considered indicative of low cross-reactivity.
Average ratios were calculated for each peptide analyzed and modes were determined for the data set presented in Table 2 (peptide 4, average of 0.55, mode
of 1; peptide 5, average of 0.24, mode of 0; peptide 6, average of 0.52, bimodal
[0 and 0.008]).

be the same. Thus, the likely explanation for the lack of, or low,
serologic response by a particular haplotype of mouse would
be an effect of the Ir gene because of the loss of T-cell epitopes.
To explore further evidence for B-cell epitopes in peptides 4,
5, and 6 of the two biotypes, we performed cross-binding assays
(Table 1). We assessed, for example, whether Cl-4-specific
antisera could bind the ET-4 peptide, which would suggest
common B-cell epitopes. The lengths of common sequences
between the classical and El Tor peptides are extensive
enough, 7 to 12 amino acids, to provide common linear B-cell
epitopes. Based on high-titer responses (homologous system)
in their tertiary serum, two mice from each of the haplotype
groups were chosen for various peptide combinations. In this
comparison, we divided the end point titer obtained in the
homologous system by the end point titer obtained in the
heterologous system analysis. If the B-cell epitopes for given

classical and ET peptides are the same or very similar, the
titers for the cross-binding assay should be identical (classical/El Tor and El Tor/classical quotients of 1 to 0.04). If there
are no common B-cell epitopes between biotype-equivalent
peptides, the titer ratio (classical/El Tor or El Tor/classical)
will be 0. If there are one or more cross-reactive B-cell
epitopes but the binding of the heterologous peptide-induced
sera is lower than that of the homologous system, the titers will
be above background but lower than those for the homologous
system (classical/El Tor or El Tor/classical quotient ratio of
0.008 to 0.002).
This analysis indicates that peptide 4 is the most crossreactive, producing an average cross-reactive score of 0.55 and
a mode of 1. Peptide 5 was the least cross-reactive peptide,
with an average of 0.24 for a cross-reactive score and a mode
of 0. Peptide 6 was cross-reactive but not as cross-reactive as
peptide 4. The average cross-reactivity score for peptide 6 was
0.52 with a dual mode of 0 or 0.008.
If one examines the peptide-haplotype combinations (Table
1) that were suggestive of the effects of the Ir gene, it is
apparent that biotype differences can affect both T- and B-cell
epitopes. The Cl-4 H-2a group reveals identity in the crossreactivity analysis, suggesting that the lack of response is not
due to lack of a common B-cell epitope. Since the class II
restriction element is the same in these haplotypes, another
explanation (effects of the class I Ir gene) is required to explain
the lack of a serologic response.
The cross-binding responses to peptide 5 are suggestive of
limited or no common B-cell epitopes. The biotype sequences
of peptide 5 have more-limited areas for B-cell epitopes because of the significant nature of the amino acid differences
between the biotypes of TcpA. The cross-binding score of Cl-5
antisera from H-2d mice is unusual in peptide 5 comparisons,
as it indicates near identity (score of 0.2 or 0.04) between Cl-5
and ET-5 for H-2d mouse sera. In particular, the changes
Cl-E158 to ET-A158, Cl-K172 to ET-A172, and Cl-D176 to
ET-N176 suggest that it would be difficult to maintain B-cell
reactivity of peptide 5, thus focusing common B-cell epitopes
on sequences in the middle of the peptide. The data in Table
1 suggest that there are not sufficient common sequences in
Cl-5 or ET-5 to accommodate Ab binding. Alternatively, the
B-cell epitopes that are immunogenic in the different biotypes
of TcpA 5 are different.
The differences in the abilities of H-2a and H-2k mice to
respond to Cl-6 and ET-6 is likely based on a change in the
B-cell epitope due to the amino acid differences between the
biotypes. The cross-binding score for these haplotype-peptide
combinations is in the middle range, suggesting positive but
not optimal binding. The dominant B-cell epitope in response
to Cl-6 or ET-6 immunization (H-2a versus H-2k) should not
change the class II binding capacity of the epitopes but does
alter binding of Abs, suggesting that the B-cell epitope(s) is
near the site of amino acid differences between the biotypes
which, because of their nature (Cl-D175 to ET-N175, Cl-G189
to ET-T189, and Cl-V195 to ET-T195) would likely be disruptive for Ab binding.
Immune indices of classical and El Tor peptides 4, 5, and 6.
The anti-peptide 4, 5, and 6 responses of mice immunized with
classical or El Tor peptides were scored as described in Materials and Methods and are shown in Table 2. The compari-
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TABLE 2. Immune indices of classical and El Tor peptides 4, 5, and 6a

Immunogen

IgG subclass

IgG1

Cl-5
ET-5
Cl-5
ET-5

IgG1

Cl-6
ET-6
Cl-6
ET-6

IgG1

Total Cl
Total ET
Haplotype total

IgG2a

IgG2a

IgG2a

H-2

b

H-2

d

Total for:
Immunogen

IgG subclass

Peptide

15
0
5
0

37.5
22.5
15
17.5

60

92.5

12.5
0
5
0

10
2.5
5
0

37.5
15
10
10

0
5
0
2.5

10
10
10
5

12.5
7.5
10
5

37.5
22.5
25
12.5

0.0
27.5
27.5

50
20
70

57.5
15
72.5

15
15
5
12.5

0
5
0
2.5

7.5
2.5
5
2.5

15
5
0
5

0
7.5
0
5

15
0
5
0
55
37.5
92.5

H-2

k

⫹32.5
52.5

72.5

⫹20
60

97.5

⫹37.5

a
The reactivity of antisera from individual haplotypes of mice to individual biotype peptides was assessed. Scoring for the individual comparisons in this table was
based on the ELISA results presented in Fig. 3 to 5, in which the anti-peptide 4, 5, and 6 responses for individual mice in the primary, secondary, and tertiary antisera
were assessed. The reactivities of the group for a given serum set were scored as follows: ⫺, 0 (no response); ⫹/⫺, 2.5 (partial response for more than one mouse but
not all); ⫹, 5 (total response). The values in this table were used to generate the rank order of the reactivity for a given peptide shown in Results.

sons in Table 2 allow the evaluation of the immunogenicity of
classical and El Tor peptides with respect to haplotypes and
the relative responsiveness with respect to IgG1 or IgG2a of
different haplotypes to classical and El Tor peptides 4, 5, and
6.
The H-2a, H-2d, and H-2k mice, which express both I-Ak/I-Ek
and I-Ad/I-Ed in general generate very good responses to classical and El Tor peptides 4, 5, and 6. The response of H-2a
mice is on average higher (92.5) than the responses of H-2d
(70) or H-2k mice (72.5). The H-2b mice are nonresponders to
classical peptides (0) but can respond to ET peptides (27.5) in
a fashion intermediate between that of H-2a (37.5), H-2d (20),
and H-2k (15) mice. The allelic differences between classical
and ET peptides provide B- and T-cell epitopes for the H-2b
mice as they can respond to ET-4, -5, or -6.
H-2a, H-2d, and H-2k mice are equally responsive to classical
peptides if all IgG subclasses are scored. In all haplotypes of
mice, immunization with classical or El Tor peptides induced
an IgG1 response that was better than the IgG2a response.
IgG2a responses to Cl-4 and ET-4 and Cl-6 and ET-6 were
comparable, while the IgG2a responses to Cl-5 and ET-5 were
lower. The differential responses of H-2a and H-2k mice are
surprising and are not correlated with class II differences but
with other H-2 region gene differences (Fig. 2).
If the immunogenicities of biotype-equivalent classical and
El Tor peptides across the haplotypes are examined, it is apparent that peptides 6 (97.5) and 4 (92.5), regardless of the
biotype, are the most immunogenic if both IgG1 and IgG2a
responses are considered. The response to peptide 5 (72.5) is
lower and more variable for the individual biotypes of peptides
and for the IgG subclasses. Clearly, peptide 5 sequences are
less immunogenic in the haplotypes of mice tested, which may
correlate with the limited class II isotype that is expressed
(I-Ab only).

DISCUSSION
Cholera remains a disease for which a universal, highly effective vaccine is lacking (3, 4). The development of a cholera
vaccine must take into account the target population and the
current biotype and serotype of the endemic or pandemic
organism. The success of the Bordetella pertussis subunit vaccine, which is based in part on the immunogenicity of three
colonization factors and their capacity to evoke protective serologic responses, has prompted us to evaluate a similar approach for V. cholerae vaccination (11). The only well-defined
colonization factor in cholera infection is TCP although it has
been suggested that others have a role (18–21). A complicating
factor in the use of TCP as an immunogen is the difficulty in
isolating endotoxin-free TcpA from cultured bacteria.
A potential TcpA vaccine that could circumvent the LPS
contamination could be based on TCP-derived peptides. TcpA
peptides have been generated based on the classical TcpA
amino acid sequences that span the C terminus of the TcpA
subunit (18). This region of TcpA is defined by a predicted ␤
hairpin turn with a disulfide bond that contains amino acids
required for assembly of the pilus and also for interaction with
either host cells or cells in the aggregated colony of bacteria
(10). Corresponding peptides from regions in El Tor TcpA
have not been investigated for their protective effect.
The synthesis of peptides corresponding to regions of TcpA
overcomes the problem of purification, but it introduces a new
problem: the potential effect of the Ir gene associated with a
limited peptide sequence available for class II binding. Effects
of the Ir gene are classically defined as lower immunogenicity
of a protein that has been linked to the lack of peptide binding
to class II molecules and thus to no or poor activation of T-cell
help for Ab production. Initial studies suggested that classical
peptides 4, 5, and 6 were immunogenic, but these studies did
not investigate enough potential class II alleles to determine if
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(MHC-like structure with bound peptides) for subsequent interactions with T cells. The Qa-2 region differences between
H-2a and H-2k mice are a less likely explanation for the lack of
response to ET-6 because theoretically nonpermissive allele
Qa-2a is associated with a positive serologic response to that
peptide by H-2b mice. However, in the ET-4 system, the nonpermissive allele, if it is Qa-2a, is associated with lack of a
response in H-2k mice and very low response in H-2d mice. One
would have to postulate two mechanisms for the different responses by H-2a and H-2k mice. Qa-2 effects could account for
the lack of peptide 4 responses, and class I differences could
account for the lack of a peptide 6 response.
While we have identified effects of the Ir gene for classical
and El Tor TcpA peptides, it is apparent that other genes can
affect the serologic response as well. The reason that H-2a mice
are such good responders is not apparent and is not related to
the Ig locus as they share that with H-2k mice. Other non-H-2
genes linked to H-2 may contribute to the differences in serologic responses. Regardless of the explanation for the differences, the effect of the Ir gene associated with the differences
in the H-2 regions suggests that vaccine peptides based on
classical and El Tor TcpA peptide 4, 5, or 6 may not be
universally efficacious in the human population. This may be
an overstatement, as the target human population is outbred at
the HLA locus. The codominant expression of human class II
molecules DR, DQ, and DP might allow more possible targets
for classical peptide- and El Tor peptide-based binding. Thus,
with more class II alleles present, it may be easier to generate
a class II peptide complex to induce T-cell help for antibody
production. It is, however, also true that certain proteins contain immunodominant epitopes for induction of responses, and
thus, while TcpA peptide 4, 5, or 6 binding may occur at a high
frequency, the peptide sequences may not be particularly immunogenic with respect to their ability to be highly expressed
and thus able to activate naive T cells. There are two solutions
to these issues. The most direct, and one that can take advantage of T-cell memory in the mucosal T-cell pool, would be to
link classical and El Tor peptide 4, 5, or 6 to a universal protein
carrier for its contribution of T-cell epitopes. A recent development by Alexander et al. could also be used by taking advantage of pan-DR epitopes that could be linked to the TcpA
peptide, thus yielding a host (human)-based vaccine design
based on known class II binding properties (1). Alternatively, a
mixture of TcpA peptides that would more effectively cover the
possible sequence solutions to MHC-II binding may be used.
These solutions would mitigate the effect of the class II Ir gene
but not the possible effect of class I or Qa-2 (perhaps not
evident in humans, as no Qa-2 gene has been identified). The
solution for the class I-based problem of the classical and El
Tor peptide sequences is to clearly identify the TcpA B-cell
epitopes within peptides 4, 5, and 6 that are immunogenic and
protective and then use minimal B-cell epitopes as haptens
associated with a universal carrier.
Clearly, the development of cholera subunit vaccines for
humans will need to take into account the route of immunization that induces the most protective isotype. Whether this is
secretory IgA or IgG is debatable, but the resolution of this
issue may dictate the route and method of immunization with
TcpA peptides. We were able to induce IgG as well as IgA
(data not shown) via intraperitoneal immunization. While this
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the effects of the Ir gene would be problematic. In this study,
we clearly demonstrate that the three most common H-2 haplotypes of mice manifest significant effects of the Ir gene with
respect to these peptides, as evidenced by different levels of
serologic responses in selected TcpA biotype and haplotype
combinations. These effects are seen in both the classical and
El Tor biotypes. Furthermore, there is a non-class II but H-2linked effect on the immunogenicities of classical and El Tor
peptides. This is seen in the response of H-2a and H-2k mice to
peptides 4 or 6. In the peptide 4 system, Cl-4 is immunogenic
in mice of both haplotypes, whereas only the H-2a mice respond to ET-4. Similarly, for peptide 6, the responses by H-2a
and H-2k mice are similar for Cl-6 but, in this comparison, H-2k
mice respond to ET-6 while H-2a mice do not.
The canonical class II peptide binding motifs for several
haplotypes are known (2, 5, 14, 23). There are preferred amino
acid residues in particular positions of the class II-bound peptide, but they are not strict requirements for binding. Other
amino acids in the “gestalt” of the bound peptide-class II
interaction interface can account for noncanonical peptideclass II interactions that result in sufficient binding for induction of T cells. Clearly, the loss of an anchor residue resulting
from the different TcpA biotype sequence could explain the
responses in H-2b mice that we report. The change in biotype
sequences and the loss of effect do not explain why mice that
express the same class II restriction elements would serologically respond in a similar or identical manner. A possible
explanation for this effect is perhaps centered in the class I
region of the H-2 locus. The H-2a and H-2k mice differ in this
region. H-2a mice are Dd Ld Qa-2a, while H-2k mice are Dk Lk
Qa-2b. MHC-I molecules are also associated with effects of the
Ir gene. This has been demonstrated by several laboratories
and also relates to the binding of peptides that influence the
subsequent immune responses. It has been established that
immunization of mice with protein antigen can result in B cells
that express class I bound with peptides from the immunizing
antigen (25). The B cells then become a target for cytotoxic
T-lymphocyte (CTL) responses that kill the B cells and thus
reduce or prevent antibody responses to the immunizing antigen. Thus, we hypothesize that, for ET-4 and ET-6, the differences in class I resulted in presented peptides that make B cells
in H-2k and H-2a mice, respectively, targets for CTL-based
elimination. Clearly, there are a number of uncharacterized
genes, with the percent contributions for these genes in congenic mice being unknown because of the unmapped recombination point. If one eliminates non-immune-related genes as
the explanation for the differences in response to ET-4 and
CL-6, then class I and Qa-2 differences are both theoretical
possibilities. Qa-2 antigens are nonclassical MHC-I molecules
with the potential to bind peptides. The Qa-2 antigen is the
product of the Ped (preimplantation embryo development)
gene and is a glycosylphosphatidylinositol-linked cell surface
protein encoded in the Q region of the mouse major histocompatibility region (13). Qa-2⫹ mice have significantly higher
preimplantation embryo cleavage rates both in vivo and in
vitro than Qa-2⫺ mice. The importance of this for immune
responses is unknown. However, Gould et al. recently presented evidence that Qa-2 can affect selection of intestinal
intraepithelial lymphocytes (6). Qa-2 has a complex role in
immunobiology. Qa-2 could serve as a restriction element
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form of immunization is not practical in humans, other routes
such as oral or intranasal routes have been shown to be responsive to immunogens by generating IgG as well as serum
IgA.
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